Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

370695 GW1929 - CAS 196808-24-9 - Calbiochem

A potent, tyrosine-based peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC₅₀ = 13 nM for murine receptor and 6.2 nM for human receptor in cell-based transactivation assays).

GW1929 - CAS 196808-24-9 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: PPAR Agonist V, PPARγ Agonist IV

Primary Target: Peroxisome proliferator-activated receptor γ (PPARγ) agonist
370695
Purchase on Sigma-Aldrich

概述

Replacement Information

重要规格表

CAS #Empirical Formula
196808-24-9C₃₀H₂₉N₃O₄

Products

产品目录编号包装 数量 / 包装
370695-1MGCN 塑胶安瓿;塑胶针药瓶 1 mg
Description
OverviewA potent, tyrosine-based peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC50 = 13 nM for murine receptor and 6.2 nM for human receptor in cell-based transactivation assays).
Catalogue Number370695
Brand Family Calbiochem®
SynonymsPPAR Agonist V, PPARγ Agonist IV
References
ReferencesHan, S., et al. 2004. Clin. Cancer Res. 10, 1911.
Willson, T.M., et al. 2000. J. Med. Chem. 43, 527.
Brown, K.K., et al. 1999. Diabetes 48, 1415.
Product Information
CAS number196808-24-9
ATP CompetitiveN
FormYellow crystalline solid
Hill FormulaC₃₀H₂₉N₃O₄
Chemical formulaC₃₀H₂₉N₃O₄
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetPeroxisome proliferator-activated receptor γ (PPARγ) agonist
Primary Target IC<sub>50</sub>EC50 = 13 nM as peroxisome proliferator-activated receptor γ (PPARγ) agonist for murine receptor and 6.2 nM for human receptor in cell-based transactivation assays
Physicochemical Information
Cell permeableN
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
370695-1MGCN 04055977191752

Documentation

GW1929 - CAS 196808-24-9 - Calbiochem MSDS

职位

物料安全数据表 (MSDS) 

GW1929 - CAS 196808-24-9 - Calbiochem 分析证书

标题批号
370695

参考

参考信息概述
Han, S., et al. 2004. Clin. Cancer Res. 10, 1911.
Willson, T.M., et al. 2000. J. Med. Chem. 43, 527.
Brown, K.K., et al. 1999. Diabetes 48, 1415.

引用

标题
  • Iwona Bogacka, et al. (2005) Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. Journal of Clinical Endocrinology and Metabolism in press,.
    		•
    数据表

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision24-August-2023 JSW
    SynonymsPPAR Agonist V, PPARγ Agonist IV
    DescriptionA potent, tyrosine-based peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC50 = 13 nM for murine PPARγ and 6.2 nM for human PPARγ in cell-based transactivation assays).
    FormYellow crystalline solid
    Intert gas (Yes/No) Packaged under inert gas
    CAS number196808-24-9
    Chemical formulaC₃₀H₂₉N₃O₄
    Structure formulaStructure formula
    SolubilityDMSO (100 mg/ml)
    Storage Protect from light
    -20°C
    Do Not Freeze Ok to freeze
    Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
    Toxicity Standard Handling
    ReferencesHan, S., et al. 2004. Clin. Cancer Res. 10, 1911.
    Willson, T.M., et al. 2000. J. Med. Chem. 43, 527.
    Brown, K.K., et al. 1999. Diabetes 48, 1415.
    Citation
  • Iwona Bogacka, et al. (2005) Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. Journal of Clinical Endocrinology and Metabolism in press,.
    		•